Marine Weill

661 total citations
13 papers, 138 citations indexed

About

Marine Weill is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Marine Weill has authored 13 papers receiving a total of 138 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in Marine Weill's work include Hemoglobinopathies and Related Disorders (4 papers), Melanoma and MAPK Pathways (4 papers) and Click Chemistry and Applications (3 papers). Marine Weill is often cited by papers focused on Hemoglobinopathies and Related Disorders (4 papers), Melanoma and MAPK Pathways (4 papers) and Click Chemistry and Applications (3 papers). Marine Weill collaborates with scholars based in Switzerland, Italy and United States. Marine Weill's co-authors include Silverio Perrotta, Antonis Kattamis, Annelore Cortoos, Vicky Huang, John B. Porter, Raffaella Origa, Alì Taher, Alexandra Kourakli, C Jacquillat and Ernesto Wasserman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Marine Weill

13 papers receiving 136 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marine Weill Switzerland 6 90 70 40 35 22 13 138
B Chen China 7 62 0.7× 185 2.6× 111 2.8× 20 0.6× 13 0.6× 9 262
Lewis Nasr United States 9 29 0.3× 80 1.1× 26 0.7× 54 1.5× 18 0.8× 27 139
Rupali Bhave United States 6 18 0.2× 86 1.2× 67 1.7× 46 1.3× 17 0.8× 18 168
Hikari Osaki United Kingdom 5 16 0.2× 67 1.0× 93 2.3× 19 0.5× 15 0.7× 5 140
Michael Pearlman United States 5 29 0.3× 26 0.4× 32 0.8× 36 1.0× 5 0.2× 9 117
Micaela Bergamaschi Italy 7 38 0.4× 79 1.1× 61 1.5× 16 0.5× 4 0.2× 11 131
M. Garcia France 6 17 0.2× 30 0.4× 69 1.7× 21 0.6× 20 0.9× 8 135
Laure Morisset France 4 39 0.4× 70 1.0× 42 1.1× 34 1.0× 2 0.1× 5 119
Nicholas F. Evageliou United States 5 17 0.2× 17 0.2× 106 2.6× 18 0.5× 11 0.5× 10 159
Lene Hyldahl Ebbesen Denmark 8 77 0.9× 152 2.2× 100 2.5× 24 0.7× 2 0.1× 13 215

Countries citing papers authored by Marine Weill

Since Specialization
Citations

This map shows the geographic impact of Marine Weill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marine Weill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marine Weill more than expected).

Fields of papers citing papers by Marine Weill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marine Weill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marine Weill. The network helps show where Marine Weill may publish in the future.

Co-authorship network of co-authors of Marine Weill

This figure shows the co-authorship network connecting the top 25 collaborators of Marine Weill. A scholar is included among the top collaborators of Marine Weill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marine Weill. Marine Weill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
3.
Taher, Alì, Raffaella Origa, Silverio Perrotta, et al.. (2017). New film‐coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower‐risk MDS: Results of the randomized, phase II ECLIPSE study. American Journal of Hematology. 92(5). 420–428. 59 indexed citations
4.
Dummer, Reinhard, Dirk Schadendorf, Paolo A. Ascierto, et al.. (2016). Results of NEMO: A phase III trial of binimetinib (BINI) vs dacarbazine (DTIC) in NRAS-mutant cutaneous melanoma.. Journal of Clinical Oncology. 34(15_suppl). 9500–9500. 24 indexed citations
5.
Taher, Alì, Raffaella Origa, Silverio Perrotta, et al.. (2016). New Film-Coated Tablet Formulation of Deferasirox Is Well Tolerated in Patients with Thalassemia or MDS: Results of the Randomized, Phase II E.C.L.I.P.S.E. Study. Blood. 128(22). 1285–1285. 4 indexed citations
6.
Taher, Alì, Raffaella Origa, Silverio Perrotta, et al.. (2016). Improved Patient-Reported Outcomes with a Film-Coated Versus Dispersible Tablet Formulation of Deferasirox: Results from the Randomized, Phase II E.C.L.I.P.S.E. Study. Blood. 128(22). 850–850. 6 indexed citations
7.
Long, Georgina V., Reinhard Dummer, Keith T. Flaherty, et al.. (2015). Abstract B16: NEMO: A phase 3 trial of binimetinib (MEK162) versus dacarbazine in patients with advanced NRAS-mutant melanoma who are untreated or have progressed on or after immunotherapy. Cancer Research. 75(14_Supplement). B16–B16. 1 indexed citations
8.
Flaherty, Keith T., Petr Arenberger, Paolo A. Ascierto, et al.. (2014). NEMO: A phase 3 trial of binimetinib (MEK162) versus dacarbazine in patients with untreated or progressed after first-line immunotherapy unresectable or metastatic NRAS-mutant cutaneous melanoma.. Journal of Clinical Oncology. 32(15_suppl). TPS9102–TPS9102. 7 indexed citations
9.
Dummer, Reinhard, Petr Arenberger, Paolo A. Ascierto, et al.. (2014). Nemo: a Phase 3 Trial of Binimetinib (Mek162) Versus Dacarbazine in Patients with Advanced Nras-Mutant Melanoma Who are Untreated or Have Progressed After Any Number of Immunotherapy Regimens. Annals of Oncology. 25. iv392–iv392. 4 indexed citations
10.
Weill, Marine, et al.. (1994). Extrapulmonary manifestations of Mycoplasma pneumoniae infections.. PubMed. 30(5-6). 412–3. 2 indexed citations
11.
Weill, Marine, et al.. (1993). Pattern of recurrence of medulloblastoma after low-dose craniospinal radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 27. 132–133. 5 indexed citations
12.
Maral, J, et al.. (1985). Phase II evaluation of diaziquone (CI-904, AZQ) in the treatment of human malignant glioma. Journal of Neuro-Oncology. 3(3). 245–249. 15 indexed citations
13.
Weill, Marine, et al.. (1970). [Curare-like action of antibiotics and potentiation of curares by antibiotics].. PubMed. 23(4). 879–84. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B Chen Breakdown of academic impact, for papers by Lewis Nasr Breakdown of academic impact, for papers by Rupali Bhave Breakdown of academic impact, for papers by Hikari Osaki Breakdown of academic impact, for papers by Michael Pearlman Breakdown of academic impact, for papers by Micaela Bergamaschi Breakdown of academic impact, for papers by M. Garcia Breakdown of academic impact, for papers by Laure Morisset Breakdown of academic impact, for papers by Nicholas F. Evageliou Breakdown of academic impact, for papers by Lene Hyldahl Ebbesen
Rankless by CCL
2026